11
Views
3
CrossRef citations to date
0
Altmetric
Research Article

New Ways of Looking at an Old Molecule

Pages 149-153 | Published online: 25 Sep 2008

References

  • Lip G. Y., Vale J. A. Does acetaminophen damage the heart?. J Toxicol Clin Toxicol 1996; 34: 145–147
  • Wakeel R. A., Davies H. T., Williams J. D. Toxic myocarditis in paracetamol poisoning. Br Med J 1987; 95: 1097
  • Weston M. J., Talbot I. C., Howorth P. J., Mant A. K., Capildeo R., Williams R. Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J 1976; 38: 1179–1188
  • Acharya S. B. Cardiac effects of paracetamol. Indian J Physiol Pharmacol 1979; 23: 239–240
  • Mann J. M., Pierre‐Louis M., Kragel P. J., Kragel A. H., Roberts W. C. Cardiac consequences of massive acetaminophen overdose. Am J Cardiol 1989; 63: 1018–1021
  • Pimstone B. L., Uys C. J. Liver necrosis and myocardio‐pathy following paracetamol overdosage. S Afr Med J 1968; 42: 259–262
  • Maclean D., Peters T. J., Brown R. A. G., McCathie M., Baines G. F., Robertson P. G. C. Treatment of acute paracetamol poisoning. Lancet 1968; 2: 849–852
  • Jones G., Thomas P. Treatment of acute paracetamol poisoning. Br Med J 1977; 2: 1224
  • Will E. J., Tomkins A. M. Acute myocardial necrosis in paracetamol poisoning. Br Med J 1971; 4: 430–431
  • Armour A., Slater S. D. Paracetamol cardiotoxicity. Postgrad Med J 1993; 69: 52–54
  • Ohtani N., Matsuzaki M., Anno Y., Ogawa H., Matsuda Y., Kusukawa R. A case of myocardial damage following acute paracetamol poisoning. Jpn Circ J 1989; 53: 278–282
  • Price L. M., Poklis A., Johnson D. E. Fatal acetaminophen poisoning with evidence of subendocardial necrosis of the heart. J Forensic Sci 1991; 36: 930–935
  • Sanerkin N. G. Acute myocardial necrosis in paracetamol poisoning. Br Med J 1971; 3: 478
  • Trey C., Davidson C. S. Progress in Liver Disease3rd Ed., H. Popper, F. Schaffner. Heinemann, London 1970; 3
  • Williams R. Fulminant viral hepatitis. Clin Gastroenterol 1974; 3: 419–436
  • Dehn H., Feil H., Rinderknecht R. E. Electrocardiographic changes in cases of infectious hepatitis. Am Heart J 1946; 31: 183
  • Saphir O., Amromin G. D., Yokoo H. Myocarditis in viral (epidemic) hepatitis. Am J Med Sci 1956; 31: 168
  • Bell H. Cardiac manifestations of viral hepatitis. JAMA 1971; 18: 387–391
  • Matsis P. P., Easthope R. N. Torsades de pointes ventricular tachycardia associated with terfenadine and paracetamol self medication. N Z Med J 1994; 107: 402–403
  • Record C. O., Lies R. A., Cohen R. D., Williams R. Acid‐base and metabolic disturbances in fulminant hepatic failure. Gut 1975; 16: 144–149
  • Oliver F., Kurien V. A., Greenwood W. Relation between serum‐free‐fatty‐acids and arrhythmias and death after acute myocardial infarction. Lancet 1968; 1: 710–714
  • Shaffer J. E., Cagen L. M., Malik K. U. Attenuation by acetaminophen or arachidonic acid‐induced coronary vasodilation and output of prostaglandins in the isolated rat heart. Eur J Pharmacol 1981; 72: 57–61
  • Robak J., Wieckowski A., Gryglewski R. The effect of 4‐acetamidophenol on prostaglandin synthetase activity in bovine and ram seminal vesicle microsomes. Biochem Pharmacol 1978; 27: 393–396
  • Zenser T. V., Mattammal M. B., Herman C. A., Joshi S., Davis B. B. Effect of acetaminophen on prostaglandin E2 and prostaglandin F2 alpha synthesis in the renal inner medulla of rat. Biochim Biophys Acta 1978; 542: 486–495
  • Horowitz J. D., Antman E. M., Lorell B. H., Barry W. H., Smith T. W. Potentiation of the cardiovascular effects of nitroglycerin by A'‐acetylcysteine. Circulation 1983; 68: 1247–1253
  • Packer M., Lee W. H., Kessler P. D., Gottlieb S. S., Medina N., Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N EnglJ Med 1987; 317: 799–804
  • May D. C., Popma J. J., Black W. H., et al. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med 1987; 317: 805–809
  • Thummel K. E., Lee C. A., Kunze K. L., Nelson S. D., Slattery J. T. Oxidation of acetaminophen to. N‐acetyl‐p‐aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993; 45: 1563–1569

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.